Portside Wealth Group »

United Therapeutics Corporation shares owned by Portside Wealth Group

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Portside Wealth Group from 13F filings

Historical chart of Portside Wealth Group investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Portside Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Portside Wealth Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $343k 703 487.25
2025-09-30 $234k 559 419.21

More positions owned by Portside Wealth Group

Spdr Series Trust State Street Spd (BIL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPYG)
Amazon (AMZN)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Series Trust State Street Spd (SPYV)
Apple (AAPL)
Visa Com Cl A (V)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)

View all positions for Portside Wealth Group

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation